Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Extended Range HRP Microwell Substrate Launched

By LabMedica International staff writers
Posted on 18 Jul 2012
AACC 2012: An extended range horseradish peroxidase (HRP) microwell substrate was launched at the American Association for Clinical Chemistry (AACC) show in Los Angeles (CA, USA), taking place from July 15-19, 2012.

A product of SurModics (Eden Prairie, MN, USA), the BioFX TMB extended range HRP microwell substrate (TMBX), when used in a quantitative assay, increases the assay's upper limit of quantization and maintains the detection limits and analytical sensitivity achieved with other TMB substrates. More...
TMBX also improves the reproducibility of the assay through lower backgrounds and better control of assay timing.

TMBX is SurModic's slowest kinetic option of TMB substrates for extended dynamic range and improved reproducibility within. It is a colorimetric substrate for HRP detection in microwell applications. TMBX is a one-component substrate that requires no preparation prior to use.

The right substrate can make a substantial contribution to the overall sensitivity of an assay. SurModics offers a variety of colorimetric TMB substrates and complementary novel stop solutions, available in both bulk and custom dispenses.

SurModics' offers new surface modification technologies and in vitro diagnostic chemical components. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities, and components for in vitro diagnostic tests and microarrays.

Related Links:

SurModics




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.